Calin G A, Gafà R, Tibiletti M G, Herlea V, Becheanu G, Cavazzini L, Barbanti-Brodano G, Nenci I, Negrini M, Lanza G
Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy.
Int J Cancer. 2000 May 20;89(3):230-5.
Colon carcinomas with microsatellite mutator phenotype exhibit specific genetic and clinico-pathological features. This report describes the analysis of 63 "microsatellite instability-high" (MSI-H) tumors for the presence of mutations in microsatellites located in the coding regions (CDRs) of 6 genes: TGFbetaRII, BAX, hMSH3, hMSH6, IGFIIR, and BLM. The following frequencies of mutations were detected: TGFbetaRII (70%), BAX (54%), hMSH3 (36.5%), IGFIIR (22%), hMSH6 (17.5%), and BLM (16%). The overall picture revealed combinations of mutations suggestive of a progressive order of accumulation, with mutations of TGFbetaRII and BAX first, followed by frameshifts in hMSH3, hMSH6, IGFIIR, and BLM. Correlations with 12 clinico-pathological parameters revealed that tumors with frameshifts in 1 or 2 CDRs were significantly better differentiated than tumors with frameshifts in more than 2 CDRs. We also found that mutations in the hMSH3 gene were significantly associated with decreased wall invasiveness and aneuploidy, and frameshifts in the BLM gene were significantly associated with the mucinous histotype. A trend toward an association between hMSH3 and IGFIIR with the medullary and conventional adenocarcinoma histotypes, respectively, was seen. Our results strengthen the concept that mutations in target genes have a role in the tumorigenic process of MSI-H tumors, and indicate that frameshifts in microsatellites located in CDRs occur in a limited number of combinations that could determine distinct clinico-pathological traits.
具有微卫星突变体表型的结肠癌表现出特定的遗传和临床病理特征。本报告描述了对63例“微卫星高度不稳定”(MSI-H)肿瘤进行分析,检测位于6个基因编码区(CDR)的微卫星中的突变情况,这6个基因分别为:TGFβRII、BAX、hMSH3、hMSH6、IGFIIR和BLM。检测到的突变频率如下:TGFβRII(70%)、BAX(54%)、hMSH3(36.5%)、IGFIIR(22%)、hMSH6(17.5%)和BLM(16%)。总体情况显示,突变组合提示存在渐进性积累顺序,首先是TGFβRII和BAX的突变,随后是hMSH3、hMSH6、IGFIIR和BLM的移码突变。与12个临床病理参数的相关性分析显示,1个或2个CDR发生移码突变的肿瘤比2个以上CDR发生移码突变的肿瘤分化程度明显更好。我们还发现,hMSH3基因的突变与壁浸润性降低和非整倍体显著相关,而BLM基因的移码突变与黏液组织学类型显著相关。分别观察到hMSH3和IGFIIR与髓样和传统腺癌组织学类型之间存在关联趋势。我们的结果强化了这样的概念,即靶基因的突变在MSI-H肿瘤的致瘤过程中起作用,并表明位于CDR的微卫星移码突变以有限的组合形式出现,这些组合可能决定不同的临床病理特征。